X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (376) 376
Paper (120) 120
Publication (119) 119
Book / eBook (29) 29
Report (22) 22
Newspaper Article (5) 5
Data Set (3) 3
Book Review (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (134) 134
physics (125) 125
high energy physics - experiment (124) 124
particle physics (120) 120
physics - high energy physics - experiment (114) 114
hep (110) 110
high energy physics (92) 92
cern lhc coll (86) 86
experimental results (77) 77
p p: scattering (69) 69
13000 gev-cms (67) 67
p p: colliding beams (65) 65
phenomenology (62) 62
index medicus (61) 61
ex (57) 57
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (53) 53
humans (50) 50
nuclear experiment (40) 40
subatomic physics (38) 38
subatomär fysik (38) 38
female (35) 35
analysis (29) 29
physics of elementary particles and fields (28) 28
background (27) 27
hadron-hadron scattering (24) 24
male (24) 24
physical sciences (24) 24
astrophysics (23) 23
hep-ex (23) 23
natural sciences (23) 23
naturvetenskap (23) 23
fysik (22) 22
particle physics - experiment (22) 22
middle aged (21) 21
multidisciplinary sciences (20) 20
mass dependence (19) 19
adult (18) 18
aged (18) 18
channel cross section: branching ratio: upper limit (18) 18
mars (16) 16
channel cross section: upper limit (15) 15
high energy astrophysical phenomena (15) 15
nuclear and particle physics. atomic energy. radioactivity (15) 15
atlas (14) 14
scattering [p p] (14) 14
sciences of the universe (14) 14
bottom: particle identification (13) 13
final state:jet lepton (13) 13
mass spectrum: (13) 13
z0: leptonic decay (13) 13
animals (12) 12
chemistry, physical (12) 12
colliding beams [p p] (12) 12
data analysis method (12) 12
earth sciences (12) 12
materials science, multidisciplinary (12) 12
nanoscience & nanotechnology (12) 12
nucl (12) 12
nuclear physics (12) 12
physics, particles & fields (12) 12
resonance: production (12) 12
物理学 (12) 12
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (11) 11
adolescent (11) 11
aerospace engineering (11) 11
atmosfärsvetenskap (11) 11
atmospheric science (11) 11
chemistry (11) 11
chemistry, applied (11) 11
engineering and technology (11) 11
jet: bottom (11) 11
maskinteknik (11) 11
mechanical engineering (11) 11
particle physics experiments (11) 11
rymd- och flygteknik (11) 11
teknik och teknologier (11) 11
top: pair production (11) 11
elementary particles, quantum field theory (10) 10
higgs particle: hadronic decay (10) 10
oncology (10) 10
quantum field theories, string theory (10) 10
research (10) 10
breast cancer (9) 9
cancer (9) 9
chirality (9) 9
ciências físicas [ciências naturais] (9) 9
large hadron collider (9) 9
science & technology (9) 9
statistical analysis (9) 9
z0: pair production (9) 9
[ sdu.stu ] sciences of the universe [physics]/earth sciences (8) 8
article (8) 8
astronomy & astrophysics (8) 8
benchmark (8) 8
chemistry, multidisciplinary (8) 8
electron (8) 8
final state:jet (8) 8
historia (8) 8
medical research (8) 8
muon: pair production (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (13) 13
UTL at Downsview - May be requested (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Scarborough - Stacks (2) 2
New College (Ivey) - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Reference (1) 1
Robarts - Storage (1) 1
Thomas Fisher Rare Book - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cadernos de Saúde Pública, ISSN 0102-311X, 2018, Volume 34, Issue 12
Resumen: El objetivo fue estimar el efecto del aseguramiento en salud sobre la supervivencia global y libre de enfermedad en pacientes con cáncer de mama. La... 
Journal Article
Revista Colombiana de Cancerología, ISSN 0123-9015, 2018, Volume 22, Issue 3, pp. 112 - 118
Resumen Introducción Existen múltiples factores pronóstico de la supervivencia en el cáncer de mama metastásico (CMM). Los dos factores mejor estudiados son la... 
Hematology, Oncology, and Palliative Medicine | Metástasis de la neoplasia | Neoplasm Metastasis | Cáncer de mama | Breast cancer | Receptor ErbB-2 | Survival | Supervivencia
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
CADERNOS DE SAUDE PUBLICA, ISSN 0102-311X, 2018, Volume 34, Issue 12, p. e00114117
The study aimed to estimate the effect of health insurance on overall survival and disease-free survival in breast cancer patients undergoing surgery at the... 
DIAGNOSIS | Health Status Disparities | Breast Neoplasms | Survival | CARE | WOMEN | INSTITUTE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Social Welfare | DISPARITIES | RADIOTHERAPY | OUTCOMES | DELAY | Breast Neoplasms - therapy | Colombia | Disease-Free Survival | Life Expectancy | Humans | Middle Aged | Adolescent | Kaplan-Meier Estimate | Female | Insurance, Health | Cohort Studies
Journal Article
Cadernos de Saúde Pública, ISSN 1678-4464, 01/2019, Volume 34, Issue 12
Resumen: El objetivo fue estimar el efecto del aseguramiento en salud sobre la supervivencia global y libre de enfermedad en pacientes con cáncer de mama. La... 
Neoplasias de la Mama | Supervivencia (Salud Pública) | Disparidades en el Estado de Salud | Bienestar Social
Journal Article
by Leiter, L. A and Lundman, P and da Silva, P. M and xel, H and Jünger, C and Gitt, A. K and Absenger, Guun and Albrich, Ernst and Allinger, Berndt and Allinger, Stephan and Anacher, Gerald and Angermayr, Gertraud and Angermeier, Hermann and Anzengruber, Aneas and Archimanitis, Gabriele and Arnsteiner, Patricia and Auberger, Wolfgang and Azhary, Mawaheb and Barfuss, Michael and Bauer, Christian and Bauer, Birgit Elisabeth and Beclin, Thomas and Binder, Thomas and Binder, Gabriele and Böhler, Dietmar and Brändle, Johann and Breslmair, Jörg and Brettlecker, Marlis and Bürger, Michael and Calvi, Inge and Dorfinger, Werner and Doringer-Schnepf, Elisabeth and Eer, Anton and Eckmayr, Christine and Eder, Franz and Egermann, Margit and Erath, Michael and Etzinger, Michael and Etzinger, Claudia and Fiedler, Lothar and Filip, Wolfgang and Filip, Michaela and Föchterle, Johann and Fodor, Anita and Frieden, Thomas and Gareiss, Mertens and Gföllner, Peter and Ghamarian, Thomas and Goritschan, Michael and Haar, Klaus and Habeler, Gerhard and Hadjiivanov, Valery and Haiböck, Christian and Hammer, Regina and Hartmann, Siegfried and Haschkovitz, Herbert and Hauer, Walter and Hauer, Josef and Haunschmidt, Christian and Heimayr, Christine and Hengl, Wolfgang and Hengl, Gunter and Hermann, Rudolf and Herrmann, Rainer and Hillebrand, Roswitha and Hintersteininger, Otto and Hirsch, Michael and Hitzinger, Martin and Hochegger, Tanja and Hockl, Wolfgang and Hoi, Michael and Hörmann, Jan and Hudler, Brigitte and Imb, Gerhard and Joichl, Anea and Jungbauer, Karl and Kapl, Gerlinde and Kerschbaum, Margit and Kienesberger, Franz and Killinger, Gerhard and Kitzler, Gerhard and Klein, Franz and Kleinbichler, Dietmar and Kohr, Anton and Kopetzky, Michael and Korthals, Christian and Kortschak, Werner and Koschutnik, Martin and Kraus, Werner A and Kurzemann, Susanne and Lavicka, Claus and Lehner, Guido and Lenz, Jürgen and Lepuschütz, Sabine and Lichtenwallner, Michael and Lober, Reinhard and Loidl, Christine and Lopatka, Eduard and Ludwig, Rudolf and Maca, Thomas and ... and DYSIS Investigators and DYSIS investigators
Diabetic medicine, ISSN 0742-3071, 2011, Volume 28, Issue 11, pp. 1343 - 1351
To assess the prevalence of persistent lipid abnormalities in statin-treated patients with diabetes with and without the metabolic syndrome. This was a... 
metabolic syndrome | cardiovascular disease | diabetes mellitus | dyslipidaemia | statins | Cardiovascular disease | Dyslipidaemia | Metabolic syndrome | Diabetes mellitus | Statins | METAANALYSIS | GUIDELINES | PREVENTION | DENSITY-LIPOPROTEIN CHOLESTEROL | THERAPY | REDUCTION | ENDOCRINOLOGY & METABOLISM | CORONARY-HEART-DISEASE | CLINICAL-PRACTICE | CARDIOVASCULAR RISK | LOW HDL-CHOLESTEROL | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Diabetic Angiopathies - etiology | Male | Metabolic Syndrome - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Metabolic Syndrome - blood | Canada - epidemiology | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Dyslipidemias - etiology | Diabetes Mellitus, Type 2 - complications | Metabolic Syndrome - epidemiology | Cardiovascular Diseases - etiology | Diabetic Angiopathies - chemically induced | Cross-Sectional Studies | Cholesterol, HDL - drug effects | Europe - epidemiology | Cholesterol, LDL - drug effects | Diabetic Angiopathies - blood | Anticholesteremic Agents - adverse effects | Metabolic Syndrome - complications | Diabetes Mellitus, Type 2 - blood | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Dyslipidemias - chemically induced | Cholesterol, HDL - blood | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetics | Blood cholesterol | Simvastatin | Low density lipoproteins | Triglycerides | Diabetes | Risk factors | Trans fatty acids
Journal Article